Surface Oncology to Present at the Baird Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvi …
(Orginal – Story lesen…)